期刊文献+

砷剂诱导多发性骨髓瘤细胞socs-1基因去甲基化作用的研究 被引量:5

Arsenic Trioxide Induces socs-1 Gene Demethylation in Myeloma Cell Lines
暂未订购
导出
摘要 本研究探讨三氧化二砷(As2O3)对人多发性骨髓瘤细胞株U266、RPMI8226细胞内socs-1基因甲基化状态的影响。用MTT法观察As2O3对骨髓瘤细胞增殖情况的影响,采用甲基特异性PCR法检测As2O3作用前后骨髓瘤细胞株U266、RPMI8226socs-1基因的甲基化状态,以实时定量PCR技术定量检测细胞株给药前后socs-1基因mRNA的表达变化,流式细胞技术检测As2O3诱导的骨髓瘤细胞的凋亡情况。结果表明:人骨髓瘤细胞株U266、RPMI8226均存在不同程度的socs-1基因CpG岛甲基化,socs-1基因不表达的现象。As2O3作用72小时后socs-1基因甲基化程度明显减弱或消失,socs-1基因在mRNA水平上表达明显增强,与各野生型细胞株相比,差异具有显著性p<0.05),且细胞生长抑制明显,早期、晚期细胞凋亡比率明显升高,并呈现剂量依赖性。结论:As2O3可诱导socs-1基因甲基化状态的改变,使基因表达上调,恢复其活性,这为进一步阐明As2O3诱导骨髓瘤细胞凋亡的可能机制和As2O3治疗多发性骨髓瘤的可能机制提供新的思路和新的研究方向。 The aim of this study was to explore the effect of arsenic trioxide ( As2O3 ) on the methylation status of socs-1 gene in multiple myeloma cell lines U266, RPMI8226. The cell viability was assayed by MTT method. The methylation status of socs-1 gene was detected by methylation specific PCR. The expression of socs-1 gene mRNA was determined with real-time PCR. The cell apoptosis was analyzed by flow cytometry. The results indicated that hypermethylation of CpG island of socs-1 gene was observed without expression of socs-1 in myeloma cell lines U266. RPMI8226. The expression of socs-1 gene mRNA in each myeloma cell line increased significantly after exposure to As2O3 for 72 hours as compared with the cell lines of wild type (p 〈 0.05 ). And cell proliferation was significantly inhibited, both early apoptosis and later apoptosis ratios increased in dose-dependent manner. It is concluded that As2O3 may induce socs-1 demethylation and up-regulate the expression of the gene. This study provides a new thought and direction for exploring possible mechanism of cell apoptosis induced by As2O3 and multiple myeloma treatment by As2O3.
出处 《中国实验血液学杂志》 CAS CSCD 2008年第5期1064-1068,共5页 Journal of Experimental Hematology
基金 上海交通大学医学院院基金课题,编号05XJ21023
关键词 三氧化二砷 骨髓瘤 SOCS-1基因 基因甲基化 细胞凋亡 arsenic trioxide myeloma socs-1 gene methylation cell apoptosis
  • 相关文献

参考文献10

  • 1China CS, Kwong YL, Fung TK, et al. Methylation profiling in multiple myeloma. Leuk Res, 2004 ;28:379 - 385
  • 2Yamamoto M, Nishimoto N, Davydova J, et al. Suppressor of cytokine signalling-/ expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells. Cancer G-erie Ther, 2006;13:194 -202
  • 3Yoshikawa H, Matsubara K, Qian GS, et al. socs-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatoeellular carcinoma and shows growth-suppression activity. Nat Genet,2001 ;28:29 -35
  • 4戎叶飞,秦新裕,靳大勇,秦莹,楼文晖,江山,吴文川,倪晓凌.胰腺癌SOCS-1基因异常甲基化研究[J].外科理论与实践,2006,11(6):519-522. 被引量:4
  • 5Sutherland KD, Lindeman GJ, Choong DY, et al. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene, 2004; 23: 7726- 7733
  • 6Cooney RN. Suppressors of cytokine signalling ( SOCS ) : inhibitors of the JAK/STAT pathway. Shock, 2002 ; 17:83 - 90
  • 7Sehuringa JJ, van-der-Sehaaf S, Vellenga E, et al. LIF-induced STAT3 signalling in murine versus human embryonal carcinoma (EC) cells. Exp Cell Res ,2002 ;274 : 119 - 129
  • 8Baylin SB, Esteller M, Rountree MR, et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet, 2001 ; 10 : 687 - 692
  • 9Galm O, Yoshikawa H, EsteUer M, et al. sots-l, a negative regulator of cytokine signalling, is frequently silenced by methy- lation in multiple myeloma. Blood, 2003; 101:2784 -2788
  • 10傅海英,沈建箴,沈松菲,周华蓉.巢式MSP检测砷剂诱导人多发性骨髓瘤U266细胞系p16基因去甲基化及转录[J].中国实验血液学杂志,2007,15(1):79-85. 被引量:10

二级参考文献16

共引文献12

同被引文献50

  • 1孙明,胡亮杉,周健,涂三芳,卢晓珣,牛新青,郭坤元.三氧化二砷提高多发性骨髓瘤ARH-77细胞对NK细胞杀伤敏感性的研究[J].免疫学杂志,2009,25(2):154-157. 被引量:4
  • 2谭竞,刘霆,朱焕玲,孟文彤,余江.三氧化二砷对多发性骨髓瘤骨髓基质细胞增殖及分泌细胞因子的影响[J].中国实验血液学杂志,2006,14(2):258-261. 被引量:6
  • 3张之南,沈悌.血液病诊断及疗效标准(3版)[M].北京:科学出版社,2007:19,23.
  • 4YOSHIMURA A,NAKA T,KUBO M. SOCS proteins, cy- tokine signaling and immune regulation [J]. Nat Rev Im- munol, 2007,7 ( 6 ) : 454 - 465.
  • 5GAOLM O, YOSHIKAWA H, ESTELLER M, et al. SOCS- 1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma [J]. Blood, 2003,101 (7):2 784 - 2 788.
  • 6YOSHIKAWA H, MATSUBARA K, QIAN G S, et al. SO- CS-1, a negative regulator of the JAK/STAT pathway, is si- lenced by methylation in human hepatocellular carcinoma and shows growth-suppression activit [J]. Nat Genet, 2001,28( 1 ) :29 - 35.
  • 7GALM O,WILOP S, REICHELT J, et al. DNA methylation changes in multiple myeloma[ J ].Leukemia, 2004,18 ( 10 ) : 1 687- 1 692.
  • 8YAMAMOTO M, NISHIMOTO N, DAVYDOVA J, et al. S- uppressor of cytokine signaling-1 expression by infectivi- ty-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cells [J]. Cancer Gene Ther, 2006,13(2) : 194 - 202.
  • 9MELZNER I,PETER M. To the editor: silencing of the S- OCS-1 gene by CpG methylation [J]. Blood,2003, 102 (4):1 554- 1 556.
  • 10)EPIL S,SAUDEMONT A,QUESNEL B. SOCS-1 gene aethylation is frequent but does not appear to have prog-- Lostic va|ue in patients with multiple myeloma [J]. Leukemia,2003,178( ) : 1 678 - 1 679.

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部